Russia And Kazakhstan Press On With Medtech Regulatory Work In 2019
Executive Summary
Russia and Kazakhstan, two prominent members of the Eurasian Economic Union, are continuing to build national medtech regulatory infrastructures, in the shadow of the forthcoming harmonized EAEU system, of which a postponement beyond 2021 has not been ruled out.
You may also be interested in...
Eurasian Medtech System Still 'Officially Targeting' 2021 Deadline
The mood among various EAEU member states is that the deadline for system adoption should be extended beyond the end of 2021. So far, the authorities have not budged, though progress on system infrastructure continues to be made, according to local regulatory expert Alexey Stepanov.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.